Page last updated: 2024-11-06

zwittergent 3-12

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

zwittergent 3-12: zwitterionic detergent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

lauryl sulfobetaine : An ammonium betaine in which the ammonium nitrogen is substituted by dodecyl, 3-sulfatopropyl and two methyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID84703
CHEMBL ID1235854
CHEBI ID75303
SCHEMBL ID60617
MeSH IDM0106842

Synonyms (82)

Synonym
chebi:75303 ,
CHEMBL1235854
AKOS015839847
n-dodecyl-n,n-dimethyl-3-ammonio-1-propanesulfonate
3-(lauryldimethylammonio)propanesulfonate
lauryl sulfobetaine
dodecyldimethyl(3-sulphonatopropyl)ammonium
3-(dodecyldimethylammonio)propanesulfonate
zwittergent 3-12
lauryl sultaine
14933-08-5
3-[dodecyl(dimethyl)ammonio]propane-1-sulfonate
3-(dodecyldimethylammonio)propane-1-sulfonate
dodecyldimethyl(3-sulfopropyl)ammonium hydroxide inner salt
D2332
3-(lauryldimethylammonio)propane-1-sulfonate
lauryldimethyl(3-sulfopropyl)ammonium hydroxide inner salt
3-[dodecyl(dimethyl)azaniumyl]propane-1-sulfonate
n-dodecyl-n,n-dimethyl-3-amino-1-propane sulfonate
tm 3-12
unii-r6p3kw3e8u
1-dodecanaminium, n,n-dimethyl-n-(3-sulfopropyl)-, hydroxide, inner salt
n-dodecyl-n,n-dimethylammonium-1-propane-3-sulfonate
n,n-dimethyl-n-(3-sulfopropyl)-1-dodecanaminium hydroxide, inner salt
1-dodecanaminium, n,n-dimethyl-n-(3-sulfopropyl)-, inner salt
sb12
bs-12
einecs 239-002-3
zwittergent
r6p3kw3e8u ,
68201-55-8
sulfobetaine 12
cas-14933-08-5
tox21_202807
dtxcid8029078
NCGC00260353-01
dtxsid6049222 ,
D3860
n,n-dimethyl-n-(3-sulfopropyl)-1-dodecanaminium hydroxide inner salt
dodecyl sulfobetaine
FT-0629530
3-(n,n-dimethyldodecylammonio)propanesulfonate
BP-30073
SCHEMBL60617
c17h37no3s
n-dodecyl-n,n-dimethylammonio-3-propanesulfonate
3-(n,n-dimethyl-n-laurylamino)propanesulfonic acid inner salt
3-(n,n-dimethyl-1-dodecylammonium)propanesulfonate
ammonium, dodecyldimethyl(3-sulfopropyl)-, hydroxide, inner salt
3-(n-dodecyl-n,n-dimethylammonium)propane-1-sulfonic acid inner salt
laurylpropylsulfobetaine
3-(n-dodecyl-n,n-dimethylammonio)-1-propanesulfonate
3-(dodecyldimethylammonio)-1-propanesulfonate
n-dodecyl-n,n-dimethyl-3-ammonio-1-propanesulphonate
.alpha.-(dodecyldimethylammonio)--propanesulfonate
3-(n-lauryl-n,n-dimethylamino)propanesulfonate inner salt
3-(dodecyldimethylammonio)propanesulfonate inner salt
ddaps
dodecyldimethyl(3-sulfopropyl)ammonium inner salt
lauryl sultaine [inci]
3-(n,n-dimethyl-n-dodecylammonio)propane-1-sulfonate
n-dodecylsulfobetaine
n-dodecyl-n,n-dimethyl-3-ammonium-1-propanesulfonate
3-(dimethyldodecylammonio)propane-1-sulfonate
dodecyldimethyl(3-sulfopropyl)ammonium hydroxide
mfcd00036909
3-(dodecyldimethylazaniumyl)propane-1-sulfonate
AS-75101
J-008579
zwittergent 3-12 detergent
Q27145205
3-(n,n-dimethyldodecylammonio)propane sulfonate
AMY22252
3-[dimethyl(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-pentacosadeuteriododecyl)azaniumyl]propane-1-sulfonate
D70364
SB83274
?n-dodecyl-n,n-dimethyl-3-ammonio-1-propanesulfonate
CS-0185823
HY-W127620
sulfobetaine-12
SY052089
M02487

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Eventually, RMI@SDC@SB12-CS achieved a high pharmacological bioavailability of 13."( In situ rearranged multifunctional lipid nanoparticles via synergistic potentiation for oral insulin delivery.
Chu, C; Deng, Y; Gou, J; He, H; Liu, H; Tang, X; Wei, M; Xu, X; Yin, T; Zhang, Y, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" The dose-response curve of ANF stimulation of the particulate and the Triton X-100 dispersed enzyme was similar."( ANF stimulation of detergent-dispersed particulate guanylate cyclase from bovine adrenal cortex.
Cantin, M; Genest, J; Gerzer, R; Hamet, P; Pang, SC; Tremblay, J, 1986
)
0.27
" Several dose-response patterns were observed as useful for classifying compounds based on their tendency to alter membrane integrity and to partition into the lipids of membranes, as well as their propensity to form aggregates or precipitates."( Effects of membrane partitioning and other physical chemical properties on the apparent potency of "membrane active" compounds evaluated using red blood cell lysis assays.
Buxser, S; Chapman, D, 2002
)
0.31
" Understanding the formation of surfactant micelles is vital for the applications of biomedicine such as drug fabrication and smart molecular vehicles in delivering therapeutic dosage to various molecular sites."( Fluorophotometric determination of critical micelle concentration (CMC) of ionic and non-ionic surfactants with carbon dots via Stokes shift.
Lavkush Bhaisare, M; Pandey, S; Shahnawaz Khan, M; Talib, A; Wu, HF, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
detergentA surfactant (or a mixture containing one or more surfactants) having cleaning properties in dilute solutions.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
ammonium betaineAny neutral molecule having charge-separated forms with a quaternary ammonium atom which bears no hydrogen atoms and that is not adjacent to the anionic atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
mitochondrial L-carnitine shuttle88

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency31.01210.006038.004119,952.5996AID1159523
AR proteinHomo sapiens (human)Potency31.75590.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743042; AID743054; AID743063
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency11.83920.000214.376460.0339AID720691; AID720692
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency23.42410.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259401; AID1259403
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency26.67740.000323.4451159.6830AID743065; AID743067
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID537735Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID537736Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID537734Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID537733Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (83)

TimeframeStudies, This Drug (%)All Drugs %
pre-199025 (30.12)18.7374
1990's16 (19.28)18.2507
2000's22 (26.51)29.6817
2010's14 (16.87)24.3611
2020's6 (7.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.70 (24.57)
Research Supply Index4.44 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.20%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other82 (98.80%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]